R P Witherspoon
Overview
Explore the profile of R P Witherspoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Storek J, Dawson M, Lim L, Burman B, Stevens-Ayers T, Viganego F, et al.
Bone Marrow Transplant
. 2003 Dec;
33(3):337-46.
PMID: 14647254
Allogeneic hematopoietic cell transplantation is followed by humoral immunodeficiency. We evaluated whether antibody levels can be improved by recipient vaccination on day -1 and 50 and whether the levels can...
2.
Chen C, Boeckh M, Seidel K, Clark J, Kansu E, Madtes D, et al.
Bone Marrow Transplant
. 2003 Aug;
32(5):515-22.
PMID: 12942099
The incidence, etiology, outcome, and risk factors for developing pneumonia late after hematopoietic stem cell transplantation (SCT) were investigated in 1359 patients transplanted in Seattle. A total of 341 patients...
3.
Kansu E, Gooley T, Flowers M, Anasetti C, Deeg H, Nash R, et al.
Blood
. 2001 Dec;
98(13):3868-70.
PMID: 11739201
This study compared the incidence of clinical extensive chronic graft-versus-host disease (GVHD), transplantation-related mortality, survival, and relapse-free survival among recipients randomly assigned to receive a 24-month or a 6-month course...
4.
Storek J, Dawson M, Storer B, Stevens-Ayers T, Maloney D, Marr K, et al.
Blood
. 2001 May;
97(11):3380-9.
PMID: 11369627
Allogeneic peripheral blood stem cell grafts contain about 10 times more T and B cells than marrow grafts. Because these cells may survive in transplant recipients for a long time,...
5.
Witherspoon R, Deeg H, Storer B, Anasetti C, Storb R, Appelbaum F
J Clin Oncol
. 2001 Apr;
19(8):2134-41.
PMID: 11304765
Purpose: This report describes results of related or unrelated hematopoietic stem-cell transplants in 111 patients with treatment-related leukemia or myelodysplasia performed consecutively at the Fred Hutchinson Cancer Research Center between...
6.
Koc S, Leisenring W, Flowers M, Anasetti C, Deeg H, Nash R, et al.
Blood
. 2000 Nov;
96(12):3995-6.
PMID: 11090092
In a randomized, placebo-controlled, double-blind trial, thalidomide or placebo together with glucocorticoids and either cyclosporine or tacrolimus was administered as initial therapy for clinical extensive chronic graft-versus-host disease (cGVHD). All...
7.
Socie G, Curtis R, Deeg H, Sobocinski K, Filipovich A, Travis L, et al.
J Clin Oncol
. 2000 Jan;
18(2):348-57.
PMID: 10637249
Purpose: To determine the incidence of and risk factors for second malignancies after allogeneic bone marrow transplantation (BMT) for childhood leukemia. Patients And Methods: We studied a cohort of 3,...
8.
Witherspoon R, Deeg H
Haematologica
. 1999 Dec;
84(12):1085-7.
PMID: 10586209
Background And Objective: Marrow transplantation results in disease-free survival for less than one-third of patients treated for secondary leukemia. The objective of this report is to review results following allogeneic...
9.
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study
Curtis R, Travis L, Rowlings P, Socie G, Kingma D, Banks P, et al.
Blood
. 1999 Sep;
94(7):2208-16.
PMID: 10498590
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT) at 235 centers worldwide to examine the incidence of and risk factors for posttransplant lymphoproliferative disorders (PTLD). PTLD developed...
10.
Witherspoon R, McGlave P, Campbell J, Sigley T, Rolston K
Cancer Pract
. 1998 Oct;
6(4):202-5.
PMID: 9767331
No abstract available.